Unsolved problems of cytoprotective therapy in patients with coronary heart disease

Unsolved problems of cytoprotective therapy in patients with coronary heart disease

The paper gives data on the proven efficiency of myocardial cytoprotection with the pFOX inhibitors trimetazidine and meldonium for coronary heart disease. However, no algorithm has been defined for their differentiated use at different ischemic remodeling stages in these patients in terms of the me...

Full description

Bibliographic Details
Main Authors:	M E Statsenko, S V Turkina, A A Ermolenko
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2015-12-01
Series:	Терапевтический архив
Subjects:	coronary heart disease cardioprotection pfox inhibitors
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31890

Similar Items

Role of pFox inhibitors in the treatment of patients with acute myocardial ischemia
by: M E Statsenko, et al.
Published: (2014-01-01)

Heart ischemic disease and longevity: unsolved problems
by: Markova T.Yu., et al.
Published: (2015-03-01)

Rational therapy of hypertension with concomitant ischemic heart disease
by: I I Chukaeva, et al.
Published: (2014-03-01)

PATHOPHYSIOLOGICAL AND CLINICAL ASPECTS OF HIGH-DOSE ATORVASTATIN CARDIOPROTECTION IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: I. D. Astrakhantseva, et al.
Published: (2018-09-01)

Optimization of a Comprehensive Prehabilitation Program for Patients with Stable Coronary Artery Disease Undergoing Elective Coronary Artery Bypass Grafting
by: Yu. A. Argunova, et al.
Published: (2020-09-01)

Cardioprotective effect of sevoflurane in patients with coronary artery disease undergoing vascular surgery
by: Ahmed S Bassuoni, et al.
Published: (2012-01-01)

Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention
by: Konstantinos Kourtis, et al.
Published: (2024-01-01)

Combination antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: T. E. Morozova, et al.
Published: (2013-08-01)

The genetic basis for survivorship in coronary artery disease
by: Jennifer R. Dungan, et al.
Published: (2013-09-01)

SGLT2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials
by: Noor Ul Amin, et al.
Published: (2022-11-01)

The Impact of Flavonols on Cardiovascular Risk
by: Joanna Popiolek-Kalisz, et al.
Published: (2022-05-01)

Protection of coronary circulation by remote ischemic preconditioning: An intriguing research frontier
by: Elpidio Santillo, et al.
Published: (2018-01-01)

Lifestyle management for patients with coronary heart disease /
by: 388208 Miller, Nancy Houston, et al.
Published: (1995)

Empagliflozin—A New Chance for Patients with Chronic Heart Failure
by: Klaudia Kowalska, et al.
Published: (2021-12-01)

Induction of Glutathione Synthesis Provides Cardioprotection Regulating NO, AMPK and PPARa Signaling in Ischemic Rat Hearts
by: Yulia V. Goshovska, et al.
Published: (2021-06-01)

INCIDENCE OF HEART FAILURE IN DIABETICS WITH CORONARY HEART DISEASE
by: Stojan Radić, et al.
Published: (2003-01-01)

CORONARY HEART DISEASE IN YOUNG WOMEN: PROBLEMS OF DIAGNOSTICS AND PREVENTION
by: A. Yu. Lebedeva, et al.
Published: (2011-12-01)

ENDOVASCULAR TREATMENT FOR CHRONIC CORONARY OCCLUSIONS IN PATIENTS WITH CORONARY HEART DISEASE
by: R. O. Shirokov, et al.
Published: (2016-02-01)

Cancer Therapy-Induced Cardiotoxicity—A Metabolic Perspective on Pathogenesis, Diagnosis and Therapy
by: Anurag Choksey, et al.
Published: (2021-12-01)

Modern opportunities of heart rate regulation in coronary heart disease
by: N. Sh. Zagidullin, et al.
Published: (2013-10-01)

The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials
by: Fawiziah K. Alharbi, et al.
Published: (2023-12-01)

ISCHEMIC PRECONDITIONING AND ITS CARDIOPROTECTIVE EFFECT IN POST-INTERVENTION CARDIAC REHABILITATION PROGRAMMES FOR PATIENTS WITH CORONARY HEART DISEASE
by: E. S. Karpova, et al.
Published: (2012-08-01)

P2X4 receptor–eNOS signaling pathway in cardiac myocytes as a novel protective mechanism in heart failure
by: Ronghua Yang, et al.
Published: (2015-01-01)

Anatomy of the coronary arteries and localization of coronary atherosclerosis in siblings with coronary heart disease
by: Imomali H. Kamolov, et al.
Published: (2022-12-01)

Donor heart preconditioning during orthotopic transplantation
by: O.А. Loskutov, et al.
Published: (2023-10-01)

Coronary heart disease and chronic kidney disease: the possibilities of PCSK9 inhibitors in the achievement of atherogenic lipoproteins target values
by: G. S. Mal, et al.
Published: (2022-06-01)

THE RESULTS OF THE OFF-PUMP CORONARY ARTERY BYPASS OPERATIONS IN PATIENTS WITH CORONARY HEART DISEASE
by: V. A. Podkamenniy, et al.
Published: (2012-07-01)

Effect of exercise training on cardiac mitochondrial respiration, biogenesis, dynamics, and mitophagy in ischemic heart disease
by: Mary Audrey D. Viloria, et al.
Published: (2022-10-01)

Frequency of Osteoporosis in Patients with Coronary Heart Disease
by: Jasim Mohammed Taib Al-Hayali, et al.
Published: (2020-01-01)

Perioperative myocardial infarction during coronary artery bypass grafting. The main approaches to diagnosis and prevention
by: Yu. A. Argunova, et al.
Published: (2019-09-01)

Impact of drug therapy on the risk of death in patients with coronary heart disease (according to the data of registry of cardiovascular diseases, RECVASA)
by: K. G Pereverzeva, et al.
Published: (2017-09-01)

Description Of ECG Recycle and Coronary Angiography in Coronary Heart Disease Patients in dr Iskak Hospital
by: Karmiati Karmiati, et al.
Published: (2018-04-01)

64-multyslice computed tomography: detection of coronary artery disease in patients with ischemic heart disease
by: A. S. Nikonenko, et al.
Published: (2015-02-01)

Gastrointestinal Bleeding in Antithrombotic Therapy in Patients with Coronary Heart Disease: Risk Factors, Pathogenesis and Treatment
by: N. S. Lapina, et al.
Published: (2020-07-01)

Association between periodontitis and acquired coronary heart disease
by: Nadia Aftan AL Rawi, et al.
Published: (2016-06-01)

Mortality rate after coronary revascularization in heart failure patients with coronary artery disease
by: Vanessa Nader, et al.
Published: (2023-08-01)

ANTIISCHEMIC EFFECTIVENESS OF IVABRADINE AND ITS IMPACT ON MICROCIRCULATION IN PATIENTS WITH CORONARY HEART DISEASE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. A. Garganeeva, et al.
Published: (2012-08-01)

Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors
by: D I Trukhan, et al.
Published: (2014-03-01)

Interrelation of individual risk and coronary atherosclerosis in coronary heart disease prognosis
by: E. V. Kotelnikova, et al.
Published: (2004-02-01)

EARLY DIAGNOSTICS OF HEART FAILURE IN PATIENTS WITH CORONARY HEART DISEASE
by: O. V. Bulashova, et al.
Published: (2003-08-01)